Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  11/21/2007
 
Trade Name:  Omnaris Nasal Spray
 
Generic or Proper Name (*):  ciclesonide
 
Indications Studied:  Treatment of seasonal allergic rhinitis (SAR) in patients 6 through less than 12 years of age
 
Therapeutic Category:  Antihistamine
 
Ages Studied:  2-12 years
 
Study #:  1
 
Study Type:  Safety/Tolerability
 
Study Design:  Single-Blind/Placebo/Parallel Group
 
No Patients:  125
 
No Centers:  3
 
No Countries:  1
 
BPCA(B), PREA(P):  P
 
-
-